Stoke Therapeutics Inc. (STOK)
NASDAQ: STOKHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 24.29 0.00%
STOK stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.57B
- EPS (TTM)
- -$3.38
- Dividend yield
- None
- 52-week range
- 20.32 – 40.22
- Day range
- 23.95 – 24.70
- Volume / Avg
- 510.49K / 857.87K
- Beta
- —
- Shares outstanding
- 64.53M
- Next earnings
- Nov 3, 2026
52-week range
STOK stock today
Shares of Stoke Therapeutics (STOK) finished lower on Oct 7 at $24.29, a drop of 0.33% or $0.08 per share, versus the S&P 500's 0.22% decline. Shares are 39.6% below their 52-week high of $40.22, set on Mar 10, 2026 and 19.5% above the 52-week low of $20.32, near the bottom of the past year's range. STOK is down 23.5% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 11.1%.
Stoke Therapeutics has posted a net loss over the last twelve months (EPS of -$3.38), so its P/E ratio is not meaningful. Stoke Therapeutics's next earnings report is expected on Nov 3, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Stoke Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2019
Earnings
Earnings history- Next report
- Nov 3, 2026
- EPS estimate
- $-0.88
Stoke Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ETONEton Pharmaceuticals Inc. | 54.88 | +0.20% | $1.57B | vs STOK |
| OCULOcular Therapeutix Inc. | 7.23 | -1.50% | $1.59B | vs STOK |
| QUREuniQure N.V. | 23.14 | +0.35% | $1.61B | vs STOK |
| PAHCPhibro Animal Health Corporation Class A | 37.72 | +3.03% | $1.53B | vs STOK |
| CMPSCOMPASS Pathways Plc American Depository Shares | 11.69 | +1.12% | $1.62B | vs STOK |
| INVAInnoviva Inc. | 21.06 | +1.10% | $1.52B | vs STOK |
| SNDXSyndax Pharmaceuticals Inc. | 17.03 | -1.96% | $1.52B | vs STOK |
| ANIPANI Pharmaceuticals Inc. | 71.93 | +0.57% | $1.65B | vs STOK |
Indexes, lists and sector
Stoke Therapeutics stock FAQ
What is Stoke Therapeutics's stock price today?
STOK last traded at $24.29 as of Oct 7, 4:00 PM EDT, down 0.33% on the day. Prices are delayed at least 15 minutes.
When is Stoke Therapeutics's next earnings date?
Stoke Therapeutics is expected to report earnings on Tuesday, November 3, 2026. Analysts expect EPS of $-0.88.
What is the STOK 52-week high?
The 52-week high for STOK is $40.22 and the 52-week low is $20.32. The stock is currently 39.6% below its high.